Cephalexin For Suspension
Product Images NDC 68071-3587

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cephalexin (NDC 68071-3587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3587 2)

Pdp (68071 3587 2)
Cephalexin 250 mg/5 mL oral suspension label by NuCare Pharmaceuticals, Inc. The label indicates a 200 mL bottle, specifying that each 5 mL teaspoonful contains 250 mg of anhydrous cephalexin. It includes NDC 68071-3587-2, dosage instructions, storage conditions, and warnings. Manufacturer is Lupin Limited, India.*
FDA Label Image

Image (F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 01)

Image (F21f8728 C3ce 42b7 B08d 8b2cf7edc9d6 01)
Chemical structure of cephalexin for oral suspension 250 mg/5mL, showing the beta-lactam ring and key functional groups, labeled from the NuCare Pharmaceuticals, Inc. product.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.